Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study details page adds new user guidance sections and standardizes the Intervention/Treatment header; it also marks recruitment as no longer recruiting and updates the revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T15:37:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.5.4 to v3.5.5, representing a minor version update.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:46.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor release. It reflects a maintenance update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T04:29:31.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.5.3' was added, replacing the previous revision tag. This indicates a version update for the page without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:52:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:55.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition reference and linked the Genetic and Rare Diseases Information Center under Resources; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T19:40:21.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.